Monday | Newkerala.com
Ranbaxy announces USFDA approval of CIP-Isotretinoin NDA
Gurgaon/Princeton May 28 : Ranbaxy Laboratories Inc. , a wholly owned subsidiary of Ranbaxy Laboratories Limited , today announced that the U.S. Food and Drug Administration has approved Absorica, a novel, patented brand formulation of the acne medication isotretinoin, developed by Cipher, for the treatment of severe recalcitrant nodular acne.
Ranbaxy Laboratories Plans to Relaunch Skin Drug in the US
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia India's largest drug maker Ranbaxy Laboratories plans to re-launch its former flagship skincare brand Sotret in the US, that has been banned for almost four years, through a ... (more)
Ranbaxy Sales Grew Over 55% With Improvement in Base Business Profitability
The Board of Directors of Ranbaxy Laboratories Limited , at their meeting held today, took on record the unaudited results for the Quarter ended March 31, 2012 under Indian GAAP.
Ranbaxy Q1 net zooms four-fold at Rs 1,247 cr
Jobs Commodities Automobiles Insurance Real Estate Travel & Tourism Health & Pharma Lifestyle Media Power Telecom Infotech Retail Infrastructure Editor's Picks New Delhi : Drug major Ranbaxy Laboratories today said its consolidated net profit surged over four-fold to Rs 1,246.76 crore during the first quarter ended March 31, 2012, over the same ... (more)
Ranbaxy reappoints Arun Sawhney as CEO
New Delhi: Drug major Ranbaxy Laboratories on Tuesday said its shareholders have approved reappointment of Arun Sawhney as CEO and Managing Director of the company for a period of five years.